nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRA2—conduct disorder	0.846	1	CbGaD
Triazolam—GABRQ—GABA A receptor activation—GABRA2—conduct disorder	0.00533	0.0369	CbGpPWpGaD
Triazolam—GABRG3—GABA A receptor activation—GABRA2—conduct disorder	0.00439	0.0304	CbGpPWpGaD
Triazolam—GABRB1—GABA A receptor activation—GABRA2—conduct disorder	0.00432	0.0299	CbGpPWpGaD
Triazolam—GABRA6—GABA A receptor activation—GABRA2—conduct disorder	0.00409	0.0283	CbGpPWpGaD
Triazolam—GABRA4—GABA A receptor activation—GABRA2—conduct disorder	0.00404	0.0279	CbGpPWpGaD
Triazolam—GABRB2—GABA A receptor activation—GABRA2—conduct disorder	0.00369	0.0256	CbGpPWpGaD
Triazolam—GABRA5—GABA A receptor activation—GABRA2—conduct disorder	0.00359	0.0248	CbGpPWpGaD
Triazolam—GABRA3—GABA A receptor activation—GABRA2—conduct disorder	0.00352	0.0244	CbGpPWpGaD
Triazolam—GABRB3—GABA A receptor activation—GABRA2—conduct disorder	0.00344	0.0238	CbGpPWpGaD
Triazolam—GABRR1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00342	0.0237	CbGpPWpGaD
Triazolam—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.00338	0.0234	CbGpPWpGaD
Triazolam—GABRQ—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00326	0.0226	CbGpPWpGaD
Triazolam—GABRR2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00326	0.0226	CbGpPWpGaD
Triazolam—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00295	0.0204	CbGpPWpGaD
Triazolam—GABRG3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00269	0.0186	CbGpPWpGaD
Triazolam—GABRB1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00265	0.0183	CbGpPWpGaD
Triazolam—GABRA6—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00251	0.0173	CbGpPWpGaD
Triazolam—GABRA4—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00247	0.0171	CbGpPWpGaD
Triazolam—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00226	0.0157	CbGpPWpGaD
Triazolam—GABRA5—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0022	0.0152	CbGpPWpGaD
Triazolam—GABRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00216	0.0149	CbGpPWpGaD
Triazolam—GABRB3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00211	0.0146	CbGpPWpGaD
Triazolam—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00207	0.0143	CbGpPWpGaD
Triazolam—GABRR1—GABA receptor activation—GABRA2—conduct disorder	0.00182	0.0126	CbGpPWpGaD
Triazolam—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00181	0.0125	CbGpPWpGaD
Triazolam—GABRQ—GABA receptor activation—GABRA2—conduct disorder	0.00173	0.012	CbGpPWpGaD
Triazolam—GABRR2—GABA receptor activation—GABRA2—conduct disorder	0.00173	0.012	CbGpPWpGaD
Triazolam—GABRG3—GABA receptor activation—GABRA2—conduct disorder	0.00143	0.00987	CbGpPWpGaD
Triazolam—GABRB1—GABA receptor activation—GABRA2—conduct disorder	0.0014	0.00972	CbGpPWpGaD
Triazolam—GABRA6—GABA receptor activation—GABRA2—conduct disorder	0.00133	0.0092	CbGpPWpGaD
Triazolam—GABRA4—GABA receptor activation—GABRA2—conduct disorder	0.00131	0.00908	CbGpPWpGaD
Triazolam—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.0012	0.0083	CbGpPWpGaD
Triazolam—GABRA5—GABA receptor activation—GABRA2—conduct disorder	0.00117	0.00807	CbGpPWpGaD
Triazolam—GABRA3—GABA receptor activation—GABRA2—conduct disorder	0.00115	0.00792	CbGpPWpGaD
Triazolam—GABRB3—GABA receptor activation—GABRA2—conduct disorder	0.00112	0.00773	CbGpPWpGaD
Triazolam—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.0011	0.00759	CbGpPWpGaD
Triazolam—GABRQ—Orphan transporters—GABRA2—conduct disorder	0.00101	0.00699	CbGpPWpGaD
Triazolam—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00096	0.00664	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000835	0.00577	CbGpPWpGaD
Triazolam—GABRG3—Orphan transporters—GABRA2—conduct disorder	0.000832	0.00575	CbGpPWpGaD
Triazolam—GABRB1—Orphan transporters—GABRA2—conduct disorder	0.000819	0.00567	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000796	0.00551	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000796	0.00551	CbGpPWpGaD
Triazolam—GABRA6—Orphan transporters—GABRA2—conduct disorder	0.000775	0.00536	CbGpPWpGaD
Triazolam—GABRA4—Orphan transporters—GABRA2—conduct disorder	0.000765	0.00529	CbGpPWpGaD
Triazolam—Chlordiazepoxide—GABRA2—conduct disorder	0.000754	0.0848	CrCbGaD
Triazolam—GABRR1—Ion channel transport—GABRA2—conduct disorder	0.000743	0.00514	CbGpPWpGaD
Triazolam—GABRQ—Ion channel transport—GABRA2—conduct disorder	0.000708	0.0049	CbGpPWpGaD
Triazolam—GABRR2—Ion channel transport—GABRA2—conduct disorder	0.000708	0.0049	CbGpPWpGaD
Triazolam—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.0007	0.00484	CbGpPWpGaD
Triazolam—GABRA5—Orphan transporters—GABRA2—conduct disorder	0.00068	0.0047	CbGpPWpGaD
Triazolam—Clotiazepam—GABRA2—conduct disorder	0.000676	0.076	CrCbGaD
Triazolam—GABRA3—Orphan transporters—GABRA2—conduct disorder	0.000668	0.00462	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000656	0.00454	CbGpPWpGaD
Triazolam—GABRB3—Orphan transporters—GABRA2—conduct disorder	0.000652	0.00451	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000646	0.00447	CbGpPWpGaD
Triazolam—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.00064	0.00443	CbGpPWpGaD
Triazolam—Alprazolam—GABRA2—conduct disorder	0.000639	0.0718	CrCbGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000627	0.00434	CbGpPWpGaD
Triazolam—Cinolazepam—GABRA2—conduct disorder	0.000622	0.07	CrCbGaD
Triazolam—Quazepam—GABRA2—conduct disorder	0.000619	0.0696	CrCbGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000611	0.00423	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000603	0.00417	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000599	0.00414	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000599	0.00414	CbGpPWpGaD
Triazolam—Flunitrazepam—GABRA2—conduct disorder	0.000585	0.0657	CrCbGaD
Triazolam—GABRG3—Ion channel transport—GABRA2—conduct disorder	0.000583	0.00404	CbGpPWpGaD
Triazolam—GABRB1—Ion channel transport—GABRA2—conduct disorder	0.000575	0.00398	CbGpPWpGaD
Triazolam—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.00056	0.00387	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000552	0.00382	CbGpPWpGaD
Triazolam—Estazolam—GABRA2—conduct disorder	0.000547	0.0615	CrCbGaD
Triazolam—GABRA6—Ion channel transport—GABRA2—conduct disorder	0.000544	0.00376	CbGpPWpGaD
Triazolam—GABRA4—Ion channel transport—GABRA2—conduct disorder	0.000537	0.00371	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000536	0.00371	CbGpPWpGaD
Triazolam—Halazepam—GABRA2—conduct disorder	0.000531	0.0597	CrCbGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000526	0.00364	CbGpPWpGaD
Triazolam—Adinazolam—GABRA2—conduct disorder	0.000521	0.0585	CrCbGaD
Triazolam—Fludiazepam—GABRA2—conduct disorder	0.000516	0.058	CrCbGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000514	0.00356	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000505	0.00349	CbGpPWpGaD
Triazolam—Prazepam—GABRA2—conduct disorder	0.000503	0.0566	CrCbGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000493	0.00341	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.000491	0.0034	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000485	0.00336	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—GABRA2—conduct disorder	0.000481	0.00333	CbGpPWpGaD
Triazolam—GABRA5—Ion channel transport—GABRA2—conduct disorder	0.000477	0.0033	CbGpPWpGaD
Triazolam—Flurazepam—GABRA2—conduct disorder	0.000469	0.0528	CrCbGaD
Triazolam—GABRA3—Ion channel transport—GABRA2—conduct disorder	0.000468	0.00324	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000459	0.00318	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—GABRA2—conduct disorder	0.000459	0.00317	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—GABRA2—conduct disorder	0.000459	0.00317	CbGpPWpGaD
Triazolam—GABRB3—Ion channel transport—GABRA2—conduct disorder	0.000457	0.00316	CbGpPWpGaD
Triazolam—Oxazepam—GABRA2—conduct disorder	0.000455	0.0511	CrCbGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000454	0.00314	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.000449	0.00311	CbGpPWpGaD
Triazolam—Temazepam—GABRA2—conduct disorder	0.000449	0.0504	CrCbGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000441	0.00305	CbGpPWpGaD
Triazolam—Midazolam—GABRA2—conduct disorder	0.000435	0.0489	CrCbGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000415	0.00287	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000403	0.00279	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000396	0.00274	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000393	0.00272	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000386	0.00267	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000379	0.00262	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—GABRA2—conduct disorder	0.000378	0.00261	CbGpPWpGaD
Triazolam—Diazepam—GABRA2—conduct disorder	0.000373	0.0419	CrCbGaD
Triazolam—GABRB1—Neuronal System—GABRA2—conduct disorder	0.000372	0.00257	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—GABRA2—conduct disorder	0.000352	0.00244	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—GABRA2—conduct disorder	0.000348	0.0024	CbGpPWpGaD
Triazolam—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000339	0.00234	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000332	0.00229	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—GABRA2—conduct disorder	0.000318	0.0022	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00031	0.00214	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—GABRA2—conduct disorder	0.000309	0.00214	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—GABRA2—conduct disorder	0.000303	0.0021	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000302	0.00209	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0003	0.00207	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—GABRA2—conduct disorder	0.000296	0.00205	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—GABRA2—conduct disorder	0.000291	0.00201	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—COMT—conduct disorder	0.000288	0.00199	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000288	0.00199	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000286	0.00198	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000286	0.00198	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000258	0.00179	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000257	0.00178	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000254	0.00176	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000247	0.00171	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000247	0.00171	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000237	0.00164	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000236	0.00163	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000234	0.00162	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000232	0.00161	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—COMT—conduct disorder	0.000231	0.0016	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—MAOA—conduct disorder	0.00023	0.00159	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000224	0.00155	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.000221	0.00153	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—COMT—conduct disorder	0.000221	0.00153	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—COMT—conduct disorder	0.000221	0.00153	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00022	0.00152	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—MAOA—conduct disorder	0.000219	0.00152	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—MAOA—conduct disorder	0.000219	0.00152	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.000218	0.00151	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000217	0.0015	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000203	0.0014	CbGpPWpGaD
Triazolam—Chlorprothixene—HTR2A—conduct disorder	0.0002	0.0225	CrCbGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0002	0.00138	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0002	0.00138	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000198	0.00137	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.000194	0.00134	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000194	0.00134	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000193	0.00134	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000193	0.00133	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00019	0.00132	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000189	0.00131	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000189	0.00131	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000187	0.0013	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000187	0.00129	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000186	0.00129	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000186	0.00129	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000185	0.00128	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000183	0.00126	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—COMT—conduct disorder	0.000182	0.00126	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000181	0.00125	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—MAOA—conduct disorder	0.00018	0.00125	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—COMT—conduct disorder	0.000179	0.00124	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—MAOA—conduct disorder	0.000178	0.00123	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000171	0.00118	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—COMT—conduct disorder	0.000169	0.00117	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—MAOA—conduct disorder	0.000168	0.00116	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—COMT—conduct disorder	0.000167	0.00116	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—MAOA—conduct disorder	0.000166	0.00115	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000166	0.00115	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—COMT—conduct disorder	0.000166	0.00115	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000164	0.00114	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.000163	0.00113	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000163	0.00113	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00016	0.0011	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000159	0.0011	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000158	0.0011	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000158	0.00109	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000158	0.00109	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000156	0.00108	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—COMT—conduct disorder	0.000153	0.00106	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MAOA—conduct disorder	0.000152	0.00105	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—COMT—conduct disorder	0.000149	0.00103	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MAOA—conduct disorder	0.000148	0.00102	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—COMT—conduct disorder	0.000146	0.00101	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MAOA—conduct disorder	0.000145	0.001	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—COMT—conduct disorder	0.000143	0.000992	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—COMT—conduct disorder	0.000142	0.000986	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MAOA—conduct disorder	0.000142	0.000985	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MAOA—conduct disorder	0.000141	0.000979	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—COMT—conduct disorder	0.00014	0.000968	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MAOA—conduct disorder	0.000139	0.000961	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000137	0.000945	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—COMT—conduct disorder	0.000122	0.000846	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MAOA—conduct disorder	0.000121	0.00084	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00012	0.000828	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000119	0.000822	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000118	0.000817	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000104	0.00072	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—COMT—conduct disorder	0.000104	0.000717	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.000103	0.000712	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.000102	0.000707	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.82e-05	0.00061	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—COMT—conduct disorder	8.44e-05	0.000584	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—MAOA—conduct disorder	8.38e-05	0.00058	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	8.35e-05	0.000578	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	8.32e-05	0.000576	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.18e-05	0.000497	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CGA—conduct disorder	6.27e-05	0.000434	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—COMT—conduct disorder	5.57e-05	0.000385	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.53e-05	0.000382	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.49e-05	0.00038	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CGA—conduct disorder	4.54e-05	0.000314	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CGA—conduct disorder	3.93e-05	0.000272	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CGA—conduct disorder	3.2e-05	0.000221	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—COMT—conduct disorder	2.83e-05	0.000196	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MAOA—conduct disorder	2.81e-05	0.000195	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CGA—conduct disorder	2.11e-05	0.000146	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COMT—conduct disorder	2.05e-05	0.000142	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MAOA—conduct disorder	2.03e-05	0.000141	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COMT—conduct disorder	1.77e-05	0.000123	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MAOA—conduct disorder	1.76e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.71e-05	0.000118	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COMT—conduct disorder	1.44e-05	9.98e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MAOA—conduct disorder	1.43e-05	9.91e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.39e-05	9.61e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—conduct disorder	1.21e-05	8.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COMT—conduct disorder	9.52e-06	6.58e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAOA—conduct disorder	9.45e-06	6.54e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—conduct disorder	8.78e-06	6.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—conduct disorder	7.6e-06	5.26e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—conduct disorder	6.19e-06	4.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—conduct disorder	4.08e-06	2.82e-05	CbGpPWpGaD
